The story of Viagra’s patents and generic entry of sildenafil citrate is a valuable one because it covers many of the nuances of drug patenting and generic entry in the…
The post Viagra: A Complicated Case Study of Generic Drug Market Entry in the Unit…
Annual Drug Patent Expirations for ALIQOPA Aliqopa is a drug marketed by Bayer Healthcare and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Bayer Healthcare drug ALIQOPA appeared first on Dr…
Annual Drug Patent Expirations for BAXDELA Baxdela is a drug marketed by Melinta and is included in two NDAs. It is available from one supplier. There are thirteen patents protecting…
The post New patent for Melinta drug BAXDELA appeared first on DrugP…
Annual Drug Patent Expirations for BRILINTA Brilinta is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from two suppliers. There are six patents…
The post New patent expiration for Astrazeneca Pharms drug BRILINTA app…
Annual Drug Patent Expirations for PAXIL Paxil is a drug marketed by Apotex Technologies and is included in four NDAs. It is available from two suppliers. There are two patents…
The post New patent expiration for Apotex Technologies drug PAXIL appeared…
Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…
The post New tentative approval for Watson Labs drug dienoge…
This chart shows the drugs with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Portug…
Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are twenty-three…
The post New patent for Sanofi-aventis Us drug SOLIQUA 100…
Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are twenty-three…
The post New patent for Sanofi-aventis Us drug SOLIQUA 100…
Annual Drug Patent Expirations for DEXMEDETOMIDINE+HYDROCHLORIDE Dexmedetomidine Hydrochloride is a drug marketed by Accord Hlthcare, Actavis Inc, Akorn Inc, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Jiangsu Hengrui Med, Luitpold Pharms…
The post New p…